Signaling cascade that mediates endothelial nitric oxide synthase activation induced by atrial natriuretic peptide

Regulatory Peptides

Volumn 151, Issue 1-3, 2008, Pages 130-134

  Elesgaray, Rosana ^a   Caniffi, Carolina ^a   Ierace, Daniela Rodríguez ^a   Jaime, María Florencia Visintini ^a   Fellet, Andrea ^a   Arranz, Cristina ^a   Costa, María Ángeles ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Aorta artery; cGMP; Heart; Kidney; NPR A; NPR C

Indexed keywords

8 BROMO CYCLIC GMP; ATRIAL NATRIURETIC FACTOR; CYCLIC GMP DEPENDENT PROTEIN KINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANINE NUCLEOTIDE BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR B; NATRIURETIC PEPTIDE RECEPTOR C; NEURONAL NITRIC OXIDE SYNTHASE; PHOSPHOLIPASE C; PROTEIN KINASE B; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY;

ANIMALS; AORTA; ATRIAL NATRIURETIC FACTOR; ENDOTHELIUM; ENZYME ACTIVATION; GUANIDINES; HEART VENTRICLES; KIDNEY; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 56249087547     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2008.05.008     Document Type: Article

References (32)

1. de Bold A.J. Atrial natriuretic factor: a hormone produced by the heart. Science 230 (1985) 767-770
2. Anand-Srivastava M.B., and Trachte G.C. Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacol Rev 45 (1993) 455-497
3. Kuhn M. Molecular physiology of natriuretic peptide signaling. Basic Res Cardiol 99 (2004) 76-82
4. Anand-Srivastava M.B., Sehl P.D., and Lowe D.G. Cytoplasmic domain of natriuretic peptide receptor C inhibits adenylyl cyclase. Involvement of pertussis toxin-sensitive G protein. J Biol Chem 271 (1996) 19329-19330
5. Anand-Srivastava M.B. Natriuretic peptide receptor-C signaling and regulation. Peptides 26 (2005) 1044-1059
6. Pagano M., and Anand-Srivastava M.B. Cytoplasmic domain of natriuretic peptide receptor C constitutes Gi activators sequences that inhibit adenylyl cyclase activity. J Biol Chem 276 (2001) 22064-22070
7. Maack T. Receptors of atrial natriuretic factor. Annu Rev Physiol 54 (1992) 11-27
8. Porter J.G., Arften A., Fuller F., Miller J.A., Gregory L.C., and Lewicki J.A. Isolation and functional expression of the human atrial natriuretic peptide clearance receptor cDNA. Biochem Biophys Res Commun 171 (1990) 796-803
9. Alderton W.K., Cooper C.E., and Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem J 357 (2001) 593-615
10. de Forstermann U., Schmidt H.W., Pollock J.S., Sheng H., Mitchell J.A., Warner T.D., et al. Isoforms of nitric oxide synthase: characterization and purification from different cell types. Biochem Pharmacol 42 (1991) 1849-1857
11. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43 (1991) 109-142
12. Costa M.A., González Bosc L.V., Majowicz M.P., Vidal N.A., Balaszczuk A.M., and Arranz C.T. Atrial natriuretic peptide modifies arterial blood pressure through nitric oxide pathway in rats. Hypertension 35 (2000) 1119-1123
13. Costa M.A., Elesgaray R., Loria A., Balaszczuk A.M., and Arranz C. Atrial natriuretic peptide influence on nitric oxide system in kidney and heart. Regul Pept 118 3 (2004) 151-157
14. Costa M.A., Elesgaray R., Balaszczuk A.M., and Arranz C. Role of NPR-C natriuretic receptor in nitric oxide system activation induced by atrial natriuretic peptide. Regulatory Pept 135 (2006) 63-68
15. Costa M.A., Elesgaray R., Caniffi C., Fellet A., and Arranz C. Role of cardiovascular nitric oxide system on C-type natriuretic peptide effects. Biochem Biophys Res Commun 359/1 (2007) 180-186
16. Chahdi A., Daeffler L., Gies J.P., and Landry Y. Drugs interacting with G protein α subunits: selectivity and perspectives. Fundam Clin Pharmacol 12 (1998) 121-132
17. Holler C., Freissmuth M., and Nanoff C. G protein as drug targets. Cell Mol Life Sci 55 (1999) 257-270
18. Peng X., Haldar S., Deshpande S., Irani K., and Kass D.A. Wall stiffness suppresses Akt/eNOS and cytoprotection in pulse-perfused endothelium. Hypertension 41 (2003) 378-381
19. Sabbatini M.E., Vatta M., Davio C., and Bianciotti L. Am J Physiol Gastrointest Liver Physiol 292 (2007) 349-357
20. Murthy K.S., Teng B.Q., Jin J.G., and Makhlouf G.M. G protein-dependent activation of smooth muscle eNOS via natriuretic peptide clearance receptor. Am J Physiol 275 (1998) 409-416
21. Vecchione C., Maffei A., Colella S., Aretini A., Poulet R., Frati G., et al. Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes 51 (2002) 168-173
22. Nachshon S., Zamir O., Matsuda Y., and Zamir N. Effects of ANP receptor antagonists on ANP secretion from adult rat cultured atrial myocytes. Am J Physiol Endocrinol Metab 268 (1995) E428-E432
23. Calderone A., Thaik C.M., Takahashi N., Chang D.L., and Colucci W.S. Nitric oxide, atrial natriuretic peptide and cyclic GMP inhibit the growth promoting effects of norepinephrine in cardiac myocytes and fibroblasts. J Clin Invest 101 (1998) 812-818
24. Kuhn M., Roltwick R., Baba H.A., Perriard J.C., Schmitz W., and Ehler E. Progressive cardiac hypertrophy and dysfunction in atrial natriuretic peptide (GC-A) deficient mice. Heart 87 (2002) 368-374
25. Lopez M.J., Wong S.K., Kishimoto I., Dubois S., and Mach V. Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature 378 (1995) 65-68
26. William M., Hamilton E.J., Garcia A., Bundgaard H., Chia K.K., Figtree G.A., and Rasmussen H.H. Natriuretic peptides stimulate the cardiac sodium pump via NPR-C-coupled NOS activation. Am J Physiol Cell Physiol 294 (2008) C1067-C1073
27. Brunner F., and Wolkart G. Endothelial NO/cGMP system contributes to natriuretic peptide-mediated coronary and peripheral vasodilatation. Microvasc Res 61 (2001) 102-110
28. Beltowski J., and Wojcicka G. Regulation of renal tubular transport by cardiac natriuretic peptides: two decades of research. Med Sci Monit 8 (2002) 39-52
29. McLay J.S., Chatterjee P.K., Jardine A.G., and Hawksworth G.M. Atrial natriuretic factor modulates nitric oxide production: an ANF-C receptor-mediated effect. J Hypertens 13 (1995) 625-630
30. Holtback U., Kruse M.S., Brismar H., and Aperia A. Intrarenal dopamine coordinates the effect of antinatriuretic and natriuretic factors. Acta Physiol Scand 168 (2000) 215-218
31. +-ATPase activity. Regul Pept 138 (2007) 26-31
32. Costa M.A., Loria A., Marchetti M., Balaszczuk A.M., and Arranz C.T. Effects of dopamine and nitric oxide on arterial pressure and renal function in volume expansion. Clin Exp Pharmacol Physiol 29 (2002) 772-776